Latest News

Industrial supplies company MSC Industrial Direct (NYSE:MSM) will be announcing earnings results this Wednesday before the bell. Here’s what you need to know...

Workplace uniform provider UniFirst (NYSE:UNF) will be announcing earnings results this Wednesday before market hours. Here’s what you need to know. UniFirst...

Nvidia is ready to launch its next-generation chip platform, but there are other factors to consider before you buy the stock.

These three software giants have all taken a hit this year, but only one looks like a buy.

The average 55-to-59-year-old's TFSA balance is a useful benchmark, but Loblaw shows how investing well can still move the needle.

Both tech giants have suffered in the recent market pullback, but one presents a more compelling artificial intelligence growth story today.

Palantir's valuation is high, but so too is its growth rate.

This specialty pharma firm focused on pain management therapies reported a notable insider sale amid steady revenue and recent stock gains.

Intact Financial (TSX:IFC) stock is the TSX dividend fortress that just keeps delivering

This biotech innovator in cystic fibrosis therapies reported a notable insider sale, as disclosed in recent SEC filings.

The Invesco QQQ ETF is 8% below its all-time high as I write this. Is this a good buying opportunity?

These three ultra-high yields look tempting, but each one pays you in a very different (and with a very different risk) way.

Want to get more out of your TFSA? These two TSX stocks could help you grow wealth steadily over time.

See how Lundin Gold's dividends can transform your investment strategy with substantial returns during gold rallies.

Oil prices are rising, but we are nowhere near the same levels as 1973.

Tourmaline looks set up for 2026 because it’s growing production while staying disciplined on spending.

Adaptive Biotechnologies, a leader in immune-driven diagnostics, reported a notable insider sale amid strong one-year stock gains.

Even as the electric-car maker's operating margins are shrinking, the stock remains priced for perfection.

President Trump has expressed a lot of public opinions about Hormuz.

The best Canadian stocks to hold forever in a TFSA, and why CNR, BCE, and GRT.UN offer long‑term stability, income, and compounding potential.

It just announced its latest acquisition.

Ligand Pharmaceuticals, a leader in drug licensing and royalties, reported a notable insider sale amid strong recent share performance.

Here's why this oversold TSX stock, offering a dividend yield above 4%, might just be the best long-term investment you buy in 2026.

The comparison to the dot-com mania of the late 1990s, which came to a screeching halt in the early 2000s, is understandable, but it's ultimately misguided.